Circadian genes, rhythms and the biology of mood disorders

Pharmacology and Therapeutics

Volumn 114, Issue 2, 2007, Pages 222-232

  McClung, Colleen A ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Bipolar; Circadian; Depression; Light therapy; Mood; Seasonal affective disorder; Sleep deprivation

Indexed keywords

AGOMELATINE; AMINEPTINE; ANTIDEPRESSANT AGENT; FLUOXETINE; LITHIUM; MELATONIN; MOOD STABILIZER; NEUROTRANSMITTER; PINDOLOL; SEROTONIN UPTAKE INHIBITOR; VALPROIC ACID;

BIPOLAR DISORDER; BRAIN REGION; CIRCADIAN RHYTHM; DRUG EFFICACY; HUMAN; MAJOR DEPRESSION; MOLECULAR CLOCK; MOOD DISORDER; NONHUMAN; PHOTOTHERAPY; PRIORITY JOURNAL; REVIEW; SEASONAL AFFECTIVE DISORDER; SLEEP DEPRIVATION THERAPY; SLEEP DISORDER; SYSTEMATIC REVIEW; UNSPECIFIED SIDE EFFECT;

BIOLOGICAL CLOCKS; BIPOLAR DISORDER; CIRCADIAN RHYTHM; DEPRESSIVE DISORDER, MAJOR; GENE EXPRESSION; GENES; HUMANS; MOOD DISORDERS; PHOTOTHERAPY; SEASONAL AFFECTIVE DISORDER; SLEEP DEPRIVATION;

EID: 34147173300     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2007.02.003     Document Type: Review

References (160)

1. Abe H., Honma S., Namihira M., Masubuchi S., Ikeda M., Ebihara S., et al. Clock gene expressions in the suprachiasmatic nucleus and other areas of the brain during rhythm splitting in CS mice. Brain Res Mol Brain Res 87 (2001) 92-99
2. Akhisaroglu M., Kurtuncu M., Manev H., Uz T., et al. Diurnal rhythms in quinpirole-induced locomotor behaviors and striatal D2/D3 receptor levels in mice. Pharmacol Biochem Behav 80 (2005) 371-377
3. Archer S.N., Robilliard D.L., Skene D.J., Smits M., Williams A., Arendt J., et al. A length polymorphism in the circadian clock gene Per3 is linked to delayed sleep phase syndrome and extreme diurnal preference. Sleep 26 (2003) 413-415
4. Asikainen M., Deboer T., Porkka-Heiskanen T., Stenberg D., and Tobler I. Sleep deprivation increases brain serotonin turnover in the Djungarian hamster. Neurosci Lett 198 (1995) 21-24
5. Aston-Jones G., Chen S., Zhu Y., and Oshinsky M.L. A neural circuit for circadian regulation of arousal. Nat Neurosci 4 (2001) 732-738
6. Atkinson M., Kripke D.F., and Wolf S.R. Autorhythmometry in manic-depressives. Chronobiologia 2 (1975) 325-335
7. Banasr M., Soumier A., Hery M., Mocaer E., and Daszuta A. Agomelatine, a new antidepressant, induces regional changes in hippocampal neurogenesis. Biol Psychiatry 59 (2006) 1087-1096
8. Barassin S., Raison S., Saboureau M., Bienvenu C., Maitre M., Malan A., et al. Circadian tryptophan hydroxylase levels and serotonin release in the suprachiasmatic nucleus of the rat. Eur J Neurosci 15 (2002) 833-840
9. Benedetti F., Barbini B., Campori E., Colombo C., and Smeraldi E. Dopamine agonist amineptine prevents the antidepressant effect of sleep deprivation. Psychiatry Res 65 (1996) 179-184
10. Benedetti F., Barbini B., Campori E., Fulgosi M.C., Pontiggia A., and Colombo C. Sleep phase advance and lithium to sustain the antidepressant effect of total sleep deprivation in bipolar depression: new findings supporting the internal coincidence model?. J Psychiatr Res 35 (2001) 323-329
11. Benedetti F., Serretti A., Colombo C., Barbini B., Lorenzi C., Campori E., et al. Influence of CLOCK gene polymorphism on circadian mood fluctuation and illness recurrence in bipolar depression. Am J Med Genet B Neuropsychiatr Genet 123 (2003) 23-26
12. Benedetti F., Serretti A., Colombo C., Lorenzi C., Tubazio V., and Smeraldi E. A glycogen synthase kinase 3-beta promoter gene single nucleotide polymorphism is associated with age at onset and response to total sleep deprivation in bipolar depression. Neurosci Lett 368 (2004) 123-126
13. Benedetti F., Serretti A., Pontiggia A., Bernasconi A., Lorenzi C., Colombo C., et al. Long-term response to lithium salts in bipolar illness is influenced by the glycogen synthase kinase 3-beta-50 T/C SNP. Neurosci Lett 376 (2005) 51-55
14. Berger M., Vollmann J., Hohagen F., Konig A., Lohner H., Voderholzer U., et al. Sleep deprivation combined with consecutive sleep phase advance as a fast-acting therapy in depression: an open pilot trial in medicated and unmedicated patients. Am J Psychiatry 154 (1997) 870-872
15. Boivin D.B. Influence of sleep-wake and circadian rhythm disturbances in psychiatric disorders. J Psychiatry Neurosci 25 (2000) 446-458
16. Booker J.M., Hellekson C.J., Putilov A.A., and Danilenko K.V. Seasonal depression and sleep disturbances in Alaska and Siberia: a pilot study. Arctic Med Res (1991) 281-284 (Suppl)
17. Brainard G.C., Hanifin J.P., Greeson J.M., Byrne B., Glickman G., Gerner E., et al. Action spectrum for melatonin regulation in humans: evidence for a novel circadian photoreceptor. J Neurosci 21 (2001) 6405-6412
18. Bunney W.E., and Bunney B.G. Molecular clock genes in man and lower animals: possible implications for circadian abnormalities in depression. Neuropsychopharmacology 22 (2000) 335-345
19. Burgess H.J., Fogg L.F., Young M.A., and Eastman C.I. Bright light therapy for winter depression-is phase advancing beneficial?. Chronobiol Int 21 (2004) 759-775
20. Campbell S., and Macqueen G. The role of the hippocampus in the pathophysiology of major depression. J Psychiatry Neurosci 29 (2004) 417-426
21. Campbell S.S., Gillin J.C., Kripke D.F., Janowsky D.S., and Risch S.C. Lithium delays circadian phase of temperature and REM sleep in a bipolar depressive: a case report. Psychiatry Res 27 (1989) 23-29
22. Carpen J.D., Archer S.N., Skene D.J., Smits M., and von Schantz M. A single-nucleotide polymorphism in the 5′-untranslated region of the hPER2 gene is associated with diurnal preference. J Sleep Res 14 (2005) 293-297
23. Carpen J.D., von Schantz M., Smits M., Skene D.J., and Archer S.N. A silent polymorphism in the PER1 gene associates with extreme diurnal preference in humans. J Hum Genet 51 12 (2006) 1122-1125
24. Castaneda T.R., de Prado B.M., Prieto D., and Mora F. Circadian rhythms of dopamine, glutamate and GABA in the striatum and nucleus accumbens of the awake rat: modulation by light. J Pineal Res 36 (2004) 177-185
25. Checkley S.A., Murphy D.G., Abbas M., Marks M., Winton F., Palazidou E., et al. Melatonin rhythms in seasonal affective disorder. Br J Psychiatry 163 (1993) 332-337
26. Chelminski I., Ferraro F.R., Petros T.V., and Plaud J.J. An analysis of the "eveningness-morningness" dimension in "depressive" college students. J Affect Disord 52 (1999) 19-29
27. Coon S.L., McCune S.K., Sugden D., and Klein D.C. Regulation of pineal alpha1B-adrenergic receptor mRNA: day/night rhythm and beta-adrenergic receptor/cyclic AMP control. Mol Pharmacol 51 (1997) 551-557
28. Danilenko K.V., and Putilov A.A. Melatonin treatment of winter depression following total sleep deprivation: waking EEG and mood correlates. Neuropsychopharmacology 30 (2005) 1345-1352
29. Danilenko K.V., Putilov A.A., Russkikh G.S., Duffy L.K., and Ebbesson S.O. Diurnal and seasonal variations of melatonin and serotonin in women with seasonal affective disorder. Arctic Med Res 53 (1994) 137-145
30. Debruyne J.P., Noton E., Lambert C.M., Maywood E.S., Weaver D.R., and Reppert S.M. A clock shock: mouse CLOCK is not required for circadian oscillator function. Neuron 50 (2006) 465-477
31. Delagrange P., and Boutin J.A. Therapeutic potential of melatonin ligands. Chronobiol Int 23 (2006) 413-418
32. den Boer J.A., Bosker F.J., and Meesters Y. Clinical efficacy of agomelatine in depression: the evidence. Int Clin Psychopharmacol 21 Suppl 1 (2006) S21-S24
33. Desan P.H., Oren D.A., Malison R., Price L.H., Rosenbaum J., Smoller J., et al. Genetic polymorphism at the CLOCK gene locus and major depression. Am J Med Genet 96 (2000) 418-421
34. Dokucu M.E., Yu L., and Taghert P.H. Lithium- and valproate-induced alterations in circadian locomotor behavior in Drosophila. Neuropsychopharmacology 30 (2005) 2216-2224
35. Drennan M.D., Klauber M.R., Kripke D.F., and Goyette L.M. The effects of depression and age on the Horne-Ostberg morningness-eveningness score. J Affect Disord 23 (1991) 93-98
36. Dudley T.E., Dinardo L.A., and Glass J.D. In vivo assessment of the midbrain raphe nuclear regulation of serotonin release in the hamster suprachiasmatic nucleus. J Neurophysiol 81 (1999) 1469-1477
37. Easton A., Arbuzova J., and Turek F.W. The circadian Clock mutation increases exploratory activity and escape-seeking behavior. Genes Brain Behav 2 (2003) 11-19
38. Ebert D., and Berger M. Neurobiological similarities in antidepressant sleep deprivation and psychostimulant use: a psychostimulant theory of antidepressant sleep deprivation. Psychopharmacology (Berl) 140 (1998) 1-10
39. Ebert D., Feistel H., Barocka A., and Kaschka W. Increased limbic blood flow and total sleep deprivation in major depression with melancholia. Psychiatry Res 55 (1994) 101-109
40. Ebert D., Feistel H., Kaschka W., Barocka A., and Pirner A. Single photon emission computerized tomography assessment of cerebral dopamine D2 receptor blockade in depression before and after sleep deprivation-preliminary results. Biol Psychiatry 35 (1994) 880-885
41. Ebert D., Albert R., Hammon G., Strasser B., May A., and Merz A. Eye-blink rates and depression. Is the antidepressant effect of sleep deprivation mediated by the dopamine system?. Neuropsychopharmacology 15 (1996) 332-339
42. Ehlen J.C., Grossman G.H., and Glass J.D. In vivo resetting of the hamster circadian clock by 5-HT7 receptors in the suprachiasmatic nucleus. J Neurosci 21 (2001) 5351-5357
43. Foster R.G., and Helfrich-Forster C. The regulation of circadian clocks by light in fruitflies and mice. Philos Trans R Soc Lond B Biol Sci 356 (2001) 1779-1789
44. Foster R.G., Hankins M., Lucas R.J., Jenkins A., Munoz M., Thompson S., et al. Non-rod, non-cone photoreception in rodents and teleost fish. Novartis Found Symp 253 (2003) 3-23 (discussion 23-30, 52-25, 102-109)
45. Giedke H., and Schwarzler F. Therapeutic use of sleep deprivation in depression. Sleep Med Rev 6 (2002) 361-377
46. Glickman G., Byrne B., Pineda C., Hauck W.W., and Brainard G.C. Light therapy for seasonal affective disorder with blue narrow-band light-emitting diodes (LEDs). Biol Psychiatry 59 (2006) 502-507
47. Gould T.D., and Manji H.K. Glycogen synthase kinase-3: a putative molecular target for lithium mimetic drugs. Neuropsychopharmacology 30 (2005) 1223-1237
48. Granados-Fuentes D., Tseng A., and Herzog E.D. A circadian clock in the olfactory bulb controls olfactory responsivity. J Neurosci 26 (2006) 12219-12225
49. Grandin L.D., Alloy L.B., and Abramson L.Y. The social zeitgeber theory, circadian rhythms, and mood disorders: review and evaluation. Clin Psychol Rev 26 (2006) 679-694
50. Grassi Zucconi G., Cipriani S., Balgkouranidou I., and Scattoni R. 'One night' sleep deprivation stimulates hippocampal neurogenesis. Brain Res Bull 69 (2006) 375-381
51. Grossman G.H., Mistlberger R.E., Antle M.C., Ehlen J.C., and Glass J.D. Sleep deprivation stimulates serotonin release in the suprachiasmatic nucleus. NeuroReport 11 (2000) 1929-1932
52. Guillaumond F., Dardente H., Giguere V., and Cermakian N. Differential control of Bmal1 circadian transcription by REV-ERB and ROR nuclear receptors. J Biol Rhythms 20 (2005) 391-403
53. Hafen T., and Wollnik F. Effect of lithium carbonate on activity level and circadian period in different strains of rats. Pharmacol Biochem Behav 49 (1994) 975-983
54. Hamet P., and Tremblay J. Genetics of the sleep-wake cycle and its disorders. Metabolism 55 (2006) S7-S12
55. Hamon M., and Bourgoin S. Pharmacological profile of antidepressants: a likely basis for their efficacy and side effects?. Eur Neuropsychopharmacol 16 Suppl 5 (2006) S625-S632
56. Hanoun N., Mocaer E., Boyer P.A., Hamon M., and Lanfumey L. Differential effects of the novel antidepressant agomelatine (S 20098) versus fluoxetine on 5-HT1A receptors in the rat brain. Neuropharmacology 47 (2004) 515-526
57. Harms E., Young M.W., and Saez L. CK1 and GSK3 in the Drosophila and mammalian circadian clock. Novartis Found Symp 253 (2003) 267-277 (discussion 102-269, 277-284)
58. Herxheimer A. Jet lag. Clin Evid (2005) 2178-2183
59. Honma K., Honma S., Kohsaka M., and Fukuda N. Seasonal variation in the human circadian rhythm: dissociation between sleep and temperature rhythm. Am J Physiol 262 (1992) R885-R891
60. Iijima M., Nikaido T., Akiyama M., Moriya T., and Shibata S. Methamphetamine-induced, suprachiasmatic nucleus-independent circadian rhythms of activity and mPer gene expression in the striatum of the mouse. Eur J Neurosci 16 (2002) 921-929
61. Iitaka C., Miyazaki K., Akaike T., and Ishida N. A role for glycogen synthase kinase-3beta in the mammalian circadian clock. J Biol Chem 280 (2005) 29397-29402
62. Iwahana E., Akiyama M., Miyakawa K., Uchida A., Kasahara J., Fukunaga K., et al. Effect of lithium on the circadian rhythms of locomotor activity and glycogen synthase kinase-3 protein expression in the mouse suprachiasmatic nuclei. Eur J Neurosci 19 (2004) 2281-2287
63. Iwase T., Kajimura N., Uchiyama M., Ebisawa T., Yoshimura K., Kamei Y., et al. Mutation screening of the human Clock gene in circadian rhythm sleep disorders. Psychiatry Res 109 (2002) 121-128
64. Jenck F., Bos M., Wichmann J., Stadler H., Martin J.R., and Moreau J.L. The role of 5-HT2C receptors in affective disorders. Expert Opin Investig Drugs 7 (1998) 1587-1599
65. Johansson C., Willeit M., Smedh C., Ekholm J., Paunio T., Kieseppa T., et al. Circadian clock-related polymorphisms in seasonal affective disorder and their relevance to diurnal preference. Neuropsychopharmacology 28 (2003) 734-739
66. Johnsson A., Engelmann W., Pflug B., and Klemke W. Period lengthening of human circadian rhythms by lithium carbonate, a prophylactic for depressive disorders. Int J Chronobiol 8 (1983) 129-147
67. Jope R.S., and Roh M.S. Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions. Curr Drug Targets 7 (2006) 1421-1434
68. Kafka M.S., Wirz-Justice A., Naber D., Moore R.Y., and Benedito M.A. Circadian rhythms in rat brain neurotransmitter receptors. Fed Proc 42 (1983) 2796-2801
69. Katzenberg D., Young T., Finn L., Lin L., King D.P., Takahashi J.S., et al. A CLOCK polymorphism associated with human diurnal preference. Sleep 21 (1998) 569-576
70. Khaldy H., Leon J., Escames G., Bikjdaouene L., Garcia J.J., and Acuna-Castroviejo D. Circadian rhythms of dopamine and dihydroxyphenyl acetic acid in the mouse striatum: effects of pinealectomy and of melatonin treatment. Neuroendocrinology 75 (2002) 201-208
71. King D.P., Zhao Y., Sangoram A.M., Wilsbacher L.D., Tanaka M., Antoch M.P., et al. Positional cloning of the mouse circadian clock gene. Cell 89 (1997) 641-653
72. Kivela A., Kauppila A., Ylostalo P., Vakkuri O., and Leppaluoto J. Seasonal, menstrual and circadian secretions of melatonin, gonadotropins and prolactin in women. Acta Physiol Scand 132 (1988) 321-327
73. Klemfuss H. Rhythms and the pharmacology of lithium. Pharmacol Ther 56 (1992) 53-78
74. Knippschild U., Gocht A., Wolff S., Huber N., Lohler J., and Stoter M. The casein kinase 1 family: participation in multiple cellular processes in eukaryotes. Cell Signal 17 (2005) 675-689
75. Ko C.H., and Takahashi J.S. Molecular components of the mammalian circadian clock. Hum Mol Genet 15 Suppl 2 (2006) R271-R277
76. Kripke D.F., Mullaney D.J., Atkinson M., and Wolf S. Circadian rhythm disorders in manic-depressives. Biol Psychiatry 13 (1978) 335-351
77. Kurabayashi N., Hirota T., Harada Y., Sakai M., and Fukada Y. Phosphorylation of mCRY2 at Ser557 in the hypothalamic suprachiasmatic nucleus of the mouse. Chronobiol Int 23 (2006) 129-134
78. Lam R.W., and Levitan R.D. Pathophysiology of seasonal affective disorder: a review. J Psychiatry Neurosci 25 (2000) 469-480
79. Lam R.W., Levitt A.J., Levitan R.D., Enns M.W., Morehouse R., Michalak E.E., et al. The Can-SAD study: a randomized controlled trial of the effectiveness of light therapy and fluoxetine in patients with winter seasonal affective disorder. Am J Psychiatry 163 (2006) 805-812
80. Lee K.Y., Ahn Y.M., Joo E.J., Jeong S.H., Chang J.S., Kim S.C., et al. No association of two common SNPs at position-1727 A/T,-50 C/T of GSK-3 beta polymorphisms with schizophrenia and bipolar disorder of Korean population. Neurosci Lett 395 (2006) 175-178
81. Leibenluft E., and Suppes T. Treating bipolar illness: focus on treatment algorithms and management of the sleep-wake cycle. Am J Psychiatry 156 (1999) 1976-1981
82. Lenox R.H., Gould T.D., and Manji H.K. Endophenotypes in bipolar disorder. Am J Med Genet 114 (2002) 391-406
83. Leproult R., Van Onderbergen A., L'Hermite-Baleriaux M., Van Cauter E., and Copinschi G. Phase-shifts of 24-h rhythms of hormonal release and body temperature following early evening administration of the melatonin agonist agomelatine in healthy older men. Clin Endocrinol (Oxf) 63 (2005) 298-304
84. Lewy A.J., Bauer V.K., Cutler N.L., and Sack R.L. Melatonin treatment of winter depression: a pilot study. Psychiatry Res 77 (1998) 57-61
85. Lewy A.J., Bauer V.K., Cutler N.L., Sack R.L., Ahmed S., Thomas K.H., et al. Morning vs. evening light treatment of patients with winter depression. Arch Gen Psychiatry 55 (1998) 890-896
86. Lewy A.J., Lefler B.J., Emens J.S., and Bauer V.K. The circadian basis of winter depression. Proc Natl Acad Sci U S A 103 (2006) 7414-7419
87. Lockley S.W., Brainard G.C., and Czeisler C.A. High sensitivity of the human circadian melatonin rhythm to resetting by short wavelength light. J Clin Endocrinol Metab 88 (2003) 4502-4505
88. Lopez-Rodriguez F., Kim J., and Poland R.E. Total sleep deprivation decreases immobility in the forced-swim test. Neuropsychopharmacology 29 (2004) 1105-1111
89. Magnusson A., and Boivin D. Seasonal affective disorder: an overview. Chronobiol Int 20 (2003) 189-207
90. Malek Z.S., Dardente H., Pevet P., and Raison S. Tissue-specific expression of tryptophan hydroxylase mRNAs in the rat midbrain: anatomical evidence and daily profiles. Eur J Neurosci 22 (2005) 895-901
91. Mansour H.A., Wood J., Logue T., Chowdari K.V., Dayal M., Kupfer D.J., et al. Association study of eight circadian genes with bipolar I disorder, schizoaffective disorder and schizophrenia. Genes Brain Behav 5 (2006) 150-157
92. McClung C.A., Sidiropoulou K., Vitaterna M., Takahashi J.S., White F.J., Cooper D.C., et al. Regulation of dopaminergic transmission and cocaine reward by the Clock gene. Proc Natl Acad Sci U S A 102 (2005) 9377-9381
93. McDearmon E.L., Patel K.N., Ko C.H., Walisser J.A., Schook A.C., Chong J.L., et al. Dissecting the functions of the mammalian clock protein BMAL1 by tissue-specific rescue in mice. Science 314 (2006) 1304-1308
94. Michelon L., Meira-Lima I., Cordeiro Q., Miguita K., Breen G., Collier D., et al. Association study of the INPP1, 5HTT, BDNF, AP-2beta and GSK-3beta GENE variants and restrospectively scored response to lithium prophylaxis in bipolar disorder. Neurosci Lett 403 (2006) 288-293
95. Mieda M., Williams S.C., Richardson J.A., Tanaka K., and Yanagisawa M. The dorsomedial hypothalamic nucleus as a putative food-entrainable circadian pacemaker. Proc Natl Acad Sci U S A 103 (2006) 12150-12155
96. Millan M.J., Gobert A., Lejeune F., Dekeyne A., Newman-Tancredi A., Pasteau V., et al. The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytryptamine2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways. J Pharmacol Exp Ther 306 (2003) 954-964
97. Millan M.J., Brocco M., Gobert A., and Dekeyne A. Anxiolytic properties of agomelatine, an antidepressant with melatoninergic and serotonergic properties: role of 5-HT2C receptor blockade. Psychopharmacology (Berl) 177 (2005) 448-458
98. Mishima K., Tozawa T., Satoh K., Saitoh H., and Mishima Y. The 3111T/C polymorphism of hClock is associated with evening preference and delayed sleep timing in a Japanese population sample. Am J Med Genet B Neuropsychiatr Genet 133 (2005) 101-104
99. Morera A.L., and Abreu P. Seasonality of psychopathology and circannual melatonin rhythm. J Pineal Res 41 (2006) 279-283
100. Naylor E., Bergmann B.M., Krauski K., Zee P.C., Takahashi J.S., Vitaterna M.H., et al. The circadian clock mutation alters sleep homeostasis in the mouse. J Neurosci 20 (2000) 8138-8143
101. Nestler E.J. Is there a common molecular pathway for addiction?. Nat Neurosci 8 (2005) 1445-1449
102. Nestler E.J., and Carlezon Jr. W.A. The mesolimbic dopamine reward circuit in depression. Biol Psychiatry 59 (2006) 1151-1159
103. Nievergelt C.M., Kripke D.F., Remick R.A., Sadovnick A.D., McElroy S.L., Keck Jr. P.E., et al. Examination of the clock gene cryptochrome 1 in bipolar disorder: mutational analysis and absence of evidence for linkage or association. Psychiatr Genet 15 (2005) 45-52
104. Nievergelt C.M., Kripke D.F., Barrett T.B., Burg E., Remick R.A., Sadovnick A.D., et al. Suggestive evidence for association of the circadian genes PERIOD3 and ARNTL with bipolar disorder. Am J Med Genet B Neuropsychiatr Genet 141 (2006) 234-241
105. Ogden C.A., Rich M.E., Schork N.J., Paulus M.P., Geyer M.A., Lohr J.B., et al. Candidate genes, pathways and mechanisms for bipolar (manic-depressive) and related disorders: an expanded convergent functional genomics approach. Mol Psychiatry 9 (2004) 1007-1029
106. Padiath Q.S., Paranjpe D., Jain S., and Sharma V.K. Glycogen synthase kinase 3beta as a likely target for the action of lithium on circadian clocks. Chronobiol Int 21 (2004) 43-55
107. Pandi-Perumal S.R., Srinivasan V., Maestroni G.J., Cardinali D.P., Poeggeler B., and Hardeland R. Melatonin: Nature's most versatile biological signal?. FEBS J 273 (2006) 2813-2838
108. Pirovano A., Lorenzi C., Serretti A., Ploia C., Landoni S., Catalano M., et al. Two new rare variants in the circadian "clock" gene may influence sleep pattern. Genet Med 7 (2005) 455-457
109. Prickaerts J., Moechars D., Cryns K., Lenaerts I., van Craenendonck H., Goris I., et al. Transgenic mice overexpressing glycogen synthase kinase 3beta: a putative model of hyperactivity and mania. J Neurosci 26 (2006) 9022-9029
110. Redlin U. Neural basis and biological function of masking by light in mammals: suppression of melatonin and locomotor activity. Chronobiol Int 18 (2001) 737-758
111. Reick M., Garcia J.A., Dudley C., and McKnight S.L. NPAS2: an analog of clock operative in the mammalian forebrain. Science 293 (2001) 506-509
112. Reppert S.M., and Weaver D.R. Molecular analysis of mammalian circadian rhythms. Annu Rev Physiol 63 (2001) 647-676
113. Riemann D., Konig A., Hohagen F., Kiemen A., Voderholzer U., Backhaus J., et al. How to preserve the antidepressive effect of sleep deprivation: a comparison of sleep phase advance and sleep phase delay. Eur Arch Psychiatry Clin Neurosci 249 (1999) 231-237
114. Roybal, K., Theobold, D., Graham, A., DiNeri, J.A., Russo, S.J., Krishnan, V., et al., in press. Mania-like behavior induced by disruption of CLOCK. Proc Natl Acad Sci U S A, (Electronic publication ahead of print, March 19).
115. Rusting C.L., and Larsen R.J. Diurnal patterns of unpleasant mood: associations with neuroticism, depression, and anxiety. J Pers 66 (1998) 85-103
116. Sato T.K., Panda S., Miraglia L.J., Reyes T.M., Rudic R.D., McNamara P., et al. A functional genomics strategy reveals Rora as a component of the mammalian circadian clock. Neuron 43 (2004) 527-537
117. Scott A.J. Shift work and health. Prim Care 27 (2000) 1057-1079
118. Serretti A., Benedetti F., Mandelli L., Lorenzi C., Pirovano A., Colombo C., et al. Genetic dissection of psychopathological symptoms: insomnia in mood disorders and CLOCK gene polymorphism. Am J Med Genet B Neuropsychiatr Genet 121 (2003) 35-38
119. Serretti A., Artioli P., and De Ronchi D. The 5-HT2C receptor as a target for mood disorders. Expert Opin Ther Targets 8 (2004) 15-23
120. Serretti A., Cusin C., Benedetti F., Mandelli L., Pirovano A., Zanardi R., et al. Insomnia improvement during antidepressant treatment and CLOCK gene polymorphism. Am J Med Genet B Neuropsychiatr Genet 137 (2005) 36-39
121. Shieh K.R., Chu Y.S., and Pan J.T. Circadian change of dopaminergic neuron activity: effects of constant light and melatonin. NeuroReport 8 (1997) 2283-2287
122. Shiino Y., Nakajima S., Ozeki Y., Isono T., and Yamada N. Mutation screening of the human period 2 gene in bipolar disorder. Neurosci Lett 338 (2003) 82-84
123. Shirayama M., Shirayama Y., Iida H., Kato M., Kajimura N., Watanabe T., et al. The psychological aspects of patients with delayed sleep phase syndrome (DSPS). Sleep Med 4 (2003) 427-433
124. Smeraldi E., Benedetti F., Barbini B., Campori E., and Colombo C. Sustained antidepressant effect of sleep deprivation combined with pindolol in bipolar depression. A placebo-controlled trial. Neuropsychopharmacology 20 (1999) 380-385
125. Souetre E., Salvati E., Belugou J.L., Pringuey D., Candito M., Krebs B., et al. Circadian rhythms in depression and recovery: evidence for blunted amplitude as the main chronobiological abnormality. Psychiatry Res 28 (1989) 263-278
126. Spanagel R., Pendyala G., Abarca C., Zghoul T., Sanchis-Segura C., Magnone M.C., et al. The clock gene Per2 influences the glutamatergic system and modulates alcohol consumption. Nat Med 11 (2005) 35-42
127. Spittaels K., Van den Haute C., Van Dorpe J., Terwel D., Vandezande K., Lasrado R., et al. Neonatal neuronal overexpression of glycogen synthase kinase-3 beta reduces brain size in transgenic mice. Neuroscience 113 (2002) 797-808
128. Sprouse J., Braselton J., and Reynolds L. Fluoxetine modulates the circadian biological clock via phase advances of suprachiasmatic nucleus neuronal firing. Biol Psychiatry 60 (2006) 896-899
129. Srinivasan V., Smits M., Spence W., Lowe A.D., Kayumov L., Pandi-Perumal S.R., et al. Melatonin in mood disorders. World J Biol Psychiatry 7 (2006) 138-151
130. Stephan F.K. The "other" circadian system: food as a Zeitgeber. J Biol Rhythms 17 (2002) 284-292
131. Stokkan K.A., Yamazaki S., Tei H., Sakaki Y., and Menaker M. Entrainment of the circadian clock in the liver by feeding. Science 291 (2001) 490-493
132. Szczepankiewicz A., Rybakowski J.K., Suwalska A., Skibinska M., Leszczynska-Rodziewicz A., Dmitrzak-Weglarz M., et al. Association study of the glycogen synthase kinase-3beta gene polymorphism with prophylactic lithium response in bipolar patients. World J Biol Psychiatry 7 (2006) 158-161
133. Szczepankiewicz A., Skibinska M., Hauser J., Slopien A., Leszczynska-Rodziewicz A., Kapelski P., et al. Association analysis of the GSK-3beta T-50C gene polymorphism with schizophrenia and bipolar disorder. Neuropsychobiology 53 (2006) 51-56
134. Takano A., Uchiyama M., Kajimura N., Mishima K., Inoue Y., Kamei Y., et al. A missense variation in human casein kinase I epsilon gene that induces functional alteration and shows an inverse association with circadian rhythm sleep disorders. Neuropsychopharmacology 29 (2004) 1901-1909
135. Tataroglu O., Aksoy A., Yilmaz A., and Canbeyli R. Effect of lesioning the suprachiasmatic nuclei on behavioral despair in rats. Brain Res 1001 (2004) 118-124
136. Terman M., and Terman J.S. Light therapy for seasonal and nonseasonal depression: efficacy, protocol, safety, and side effects. CNS Spectr 10 (2005) 647-663 (quiz 672)
137. Terman J.S., Terman M., Lo E.S., and Cooper T.B. Circadian time of morning light administration and therapeutic response in winter depression. Arch Gen Psychiatry 58 (2001) 69-75
138. Thapan K., Arendt J., and Skene D.J. An action spectrum for melatonin suppression: evidence for a novel non-rod, non-cone photoreceptor system in humans. J Physiol 535 (2001) 261-267
139. Thase M.E. Bipolar depression: issues in diagnosis and treatment. Harv Rev Psychiatry 13 (2005) 257-271
140. Touitou Y., Fevre M., Bogdan A., Reinberg A., De Prins J., Beck H., et al. Patterns of plasma melatonin with ageing and mental condition: stability of nyctohemeral rhythms and differences in seasonal variations. Acta Endocrinol (Copenh) 106 (1984) 145-151
141. Tuma J., Strubbe J.H., Mocaer E., and Koolhaas J.M. Anxiolytic-like action of the antidepressant agomelatine (S 20098) after a social defeat requires the integrity of the SCN. Eur Neuropsychopharmacol 15 (2005) 545-555
142. Uz T., Ahmed R., Akhisaroglu M., Kurtuncu M., Imbesi M., Dirim Arslan A., et al. Effect of fluoxetine and cocaine on the expression of clock genes in the mouse hippocampus and striatum. Neuroscience 134 (2005) 1309-1316
143. Vanselow K., Vanselow J.T., Westermark P.O., Reischl S., Maier B., Korte T., et al. Differential effects of PER2 phosphorylation: molecular basis for the human familial advanced sleep phase syndrome (FASPS). Genes Dev 20 (2006) 2660-2672
144. Weber M., Lauterburg T., Tobler I., and Burgunder J.M. Circadian patterns of neurotransmitter related gene expression in motor regions of the rat brain. Neurosci Lett 358 (2004) 17-20
145. Wehr T.A., Duncan Jr. W.C., Sher L., Aeschbach D., Schwartz P.J., Turner E.H., et al. A circadian signal of change of season in patients with seasonal affective disorder. Arch Gen Psychiatry 58 (2001) 1108-1114
146. Weiner N., Clement H.W., Gemsa D., and Wesemann W. Circadian and seasonal rhythms of 5-HT receptor subtypes, membrane anisotropy and 5-HT release in hippocampus and cortex of the rat. Neurochem Int 21 (1992) 7-14
147. Welsh D.K., and Moore-Ede M.C. Lithium lengthens circadian period in a diurnal primate, Saimiri sciureus. Biol Psychiatry 28 (1990) 117-126
148. Wesemann W., and Weiner N. Circadian rhythm of serotonin binding in rat brain. Prog Neurobiol 35 (1990) 405-428
149. Wirz-Justice A., and Van den Hoofdakker R.H. Sleep deprivation in depression: what do we know, where do we go?. Biol Psychiatry 46 (1999) 445-453
150. Wirz-Justice A., Graw P., Krauchi K., Gisin B., Arendt J., Aldhous M., et al. Morning or night-time melatonin is ineffective in seasonal affective disorder. J Psychiatr Res 24 (1990) 129-137
151. Wirz-Justice A., Graw P., Krauchi K., Gisin B., Jochum A., Arendt J., et al. Light therapy in seasonal affective disorder is independent of time of day or circadian phase. Arch Gen Psychiatry 50 (1993) 929-937
152. Wirz-Justice A., Benedetti F., Berger M., Lam R.W., Martiny K., Terman M., et al. Chronotherapeutics (light and wake therapy) in affective disorders. Psychol Med 35 (2005) 939-944
153. Witte K., and Lemmer B. Rhythms in second messenger mechanisms. Pharmacol Ther 51 (1991) 231-237
154. Wu J.C., and Bunney W.E. The biological basis of an antidepressant response to sleep deprivation and relapse: review and hypothesis. Am J Psychiatry 147 (1990) 14-21
155. Xu Y., Padiath Q.S., Shapiro R.E., Jones C.R., Wu S.C., Saigoh N., et al. Functional consequences of a CKIdelta mutation causing familial advanced sleep phase syndrome. Nature 434 (2005) 640-644
156. Yin L., Wang J., Klein P.S., and Lazar M.A. Nuclear receptor Rev-erbalpha is a critical lithium-sensitive component of the circadian clock. Science 311 (2006) 1002-1005
157. Ying S.W., Rusak B., Delagrange P., Mocaer E., Renard P., and Guardiola-Lemaitre B. Melatonin analogues as agonists and antagonists in the circadian system and other brain areas. Eur J Pharmacol 296 (1996) 33-42
158. Yoneyama S., Hashimoto S., and Honma K. Seasonal changes of human circadian rhythms in Antarctica. Am J Physiol 277 (1999) R1091-R1097
159. Yuferov V., Kroslak T., Laforge K.S., Zhou Y., Ho A., and Kreek M.J. Differential gene expression in the rat caudate putamen after "binge" cocaine administration: advantage of triplicate microarray analysis. Synapse 48 (2003) 157-169
160. Zupancic M., and Guilleminault C. Agomelatine: a preliminary review of a new antidepressant. CNS Drugs 20 (2006) 981-992